Senate GOP Import Bill Will Start With Canada, Leave Expansion Up To FDA
Executive Summary
The Senate Republican leadership's reimportation bill will focus on wholesale imports from Canada and leave any decision about future expansions in parallel trade up to FDA
You may also be interested in...
Importation Limits In Future Trade Agreements Prevented Under Vitter Bill
Pharmaceutical importation prohibitions in future U.S. trade agreements would be forbidden under a bill co-sponsored by Sens. David Vitter (R-La.) and Debbie Stabenow (D-Mich.)
Importation Limits In Future Trade Agreements Prevented Under Vitter Bill
Pharmaceutical importation prohibitions in future U.S. trade agreements would be forbidden under a bill co-sponsored by Sens. David Vitter (R-La.) and Debbie Stabenow (D-Mich.)
Schering Sees No Impact From Imports; Not Attractive To “Parallel Traders”
Schering-Plough sees one advantage to operating as a smaller pharmaceutical player: little or no impact from a potential U.S.-sanctioned drug importation policy